These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 14501009)

  • 21. Strikingly reduced amyloid burden and improved behavioral performance in Alzheimer's disease mice immunized with recombinant chimeric vaccines by hexavalent foldable Aβ₁₋₁₅ fused to toxin-derived carrier proteins.
    Yu YZ; Wang WB; Chen A; Chang Q; Liu S; Zhao M; Wang S; Qiu WY; Pang XB; Xu Q; Sun ZW
    J Alzheimers Dis; 2014; 41(1):243-60. PubMed ID: 24625800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amyloid-beta immunotherapy for Alzheimer's disease.
    Fu HJ; Liu B; Frost JL; Lemere CA
    CNS Neurol Disord Drug Targets; 2010 Apr; 9(2):197-206. PubMed ID: 20205640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel monoclonal antibody against the N-terminus of Aβ1-42 reduces plaques and improves cognition in a mouse model of Alzheimer's disease.
    Xing HY; Li B; Peng D; Wang CY; Wang GY; Li P; Le YY; Wang JM; Ye G; Chen JH
    PLoS One; 2017; 12(6):e0180076. PubMed ID: 28662102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A cyclic undecamer peptide mimics a turn in folded Alzheimer amyloid β and elicits antibodies against oligomeric and fibrillar amyloid and plaques.
    Hoogerhout P; Kamphuis W; Brugghe HF; Sluijs JA; Timmermans HA; Westdijk J; Zomer G; Boog CJ; Hol EM; van den Dobbelsteen GP
    PLoS One; 2011 Apr; 6(4):e19110. PubMed ID: 21526148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined treatment of amyloid-β₁₋₄₂-stimulated bone marrow-derived dendritic cells plus splenocytes from young mice prevents the development of Alzheimer's disease in APPswe/PSENldE9 mice.
    Wang F; Liu H; Shen X; Ao H; Moore N; Gao L; Chen L; Hu H; Ma H; Yang Z; Zhai C; Qin J; Zhou G; Peng Y; Feng X; Li R; Liang C
    Neurobiol Aging; 2015 Jan; 36(1):111-22. PubMed ID: 25085784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonhuman amyloid oligomer epitope reduces Alzheimer's-like neuropathology in 3xTg-AD transgenic mice.
    Rasool S; Martinez-Coria H; Milton S; Glabe CG
    Mol Neurobiol; 2013 Dec; 48(3):931-40. PubMed ID: 23771815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Passive immunotherapy with a novel antibody against 3pE-modified Aβ demonstrates potential for enhanced efficacy and favorable safety in combination with BACE inhibitor treatment in plaque-depositing mice.
    Janssens J; Hermans B; Vandermeeren M; Barale-Thomas E; Borgers M; Willems R; Meulders G; Wintmolders C; Van den Bulck D; Bottelbergs A; Ver Donck L; Larsen P; Moechars D; Edwards W; Mercken M; Van Broeck B
    Neurobiol Dis; 2021 Jul; 154():105365. PubMed ID: 33848635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralization of soluble, synaptotoxic amyloid β species by antibodies is epitope specific.
    Zago W; Buttini M; Comery TA; Nishioka C; Gardai SJ; Seubert P; Games D; Bard F; Schenk D; Kinney GG
    J Neurosci; 2012 Feb; 32(8):2696-702. PubMed ID: 22357853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration.
    Frenkel D; Katz O; Solomon B
    Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11455-9. PubMed ID: 11027345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration.
    Wilcock DM; Munireddy SK; Rosenthal A; Ugen KE; Gordon MN; Morgan D
    Neurobiol Dis; 2004 Feb; 15(1):11-20. PubMed ID: 14751766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease.
    Schiltz JG; Salzer U; Mohajeri MH; Franke D; Heinrich J; Pavlovic J; Wollmer MA; Nitsch RM; Moelling K
    J Mol Med (Berl); 2004 Oct; 82(10):706-14. PubMed ID: 15241501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short amyloid-beta (Abeta) immunogens reduce cerebral Abeta load and learning deficits in an Alzheimer's disease mouse model in the absence of an Abeta-specific cellular immune response.
    Maier M; Seabrook TJ; Lazo ND; Jiang L; Das P; Janus C; Lemere CA
    J Neurosci; 2006 May; 26(18):4717-28. PubMed ID: 16672644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic active immunization with a novel epitope vaccine improves cognitive ability by decreasing amyloid plaques and neuroinflammation in APP/PS1 transgenic mice.
    Ding L; Meng Y; Zhang HY; Yin WC; Yan Y; Cao YP
    Neurosci Res; 2017 Jun; 119():7-14. PubMed ID: 28111220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting isoaspartate-modified Aβ rescues behavioral deficits in transgenic mice with Alzheimer's disease-like pathology.
    Gnoth K; Piechotta A; Kleinschmidt M; Konrath S; Schenk M; Taudte N; Ramsbeck D; Rieckmann V; Geissler S; Eichentopf R; Barendrecht S; Hartlage-Rübsamen M; Demuth HU; Roßner S; Cynis H; Rahfeld JU; Schilling S
    Alzheimers Res Ther; 2020 Nov; 12(1):149. PubMed ID: 33189132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparative evaluation of a novel vaccine in APP/PS1 mouse models of Alzheimer's disease.
    Carrera I; Etcheverría I; Fernández-Novoa L; Lombardi VR; Lakshmana MK; Cacabelos R; Vigo C
    Biomed Res Int; 2015; 2015():807146. PubMed ID: 25759822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Filamentous bacteriophage as a novel therapeutic tool for Alzheimer's disease treatment.
    Solomon B
    J Alzheimers Dis; 2008 Oct; 15(2):193-8. PubMed ID: 18953108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The generation and characterization of potentially therapeutic Abeta antibodies in mice: differences according to strain and immunization protocol.
    Spooner ET; Desai RV; Mori C; Leverone JF; Lemere CA
    Vaccine; 2002 Dec; 21(3-4):290-7. PubMed ID: 12450704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 4Aβ1-15-Derived Monoclonal Antibody Reduces More Aβ Burdens and Neuroinflammation than Homologous Vaccine in APP/PS1 Mice.
    Zhang Y; Zou J; Yang J; Yao Z
    Curr Alzheimer Res; 2015; 12(4):384-97. PubMed ID: 25817256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic Vaccine Based on Pyroglutamate-3 Amyloid β Generates Strong Antibody Response and Rescues Cognitive Decline in Alzheimer's Disease Model Mice.
    Li G; Hu ZW; Chen PG; Sun ZY; Chen YX; Zhao YF; Li YM
    ACS Chem Neurosci; 2017 Mar; 8(3):454-459. PubMed ID: 28292186
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Passive Aβ Immunotherapy: Current Achievements and Future Perspectives.
    Schilling S; Rahfeld JU; Lues I; Lemere CA
    Molecules; 2018 May; 23(5):. PubMed ID: 29751505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.